Anaemia in a phase 2 study of a blood stage falciparum malaria vaccine

BACKGROUND: A Phase 1-2b study of the blood stage malaria vaccine AMA1-C1/Alhydrogel was conducted in 336 children in Donéguébougou and Bancoumana, Mali. In the Phase 2 portion of the study (n = 300), no impact on parasite density or clinical malaria was seen; however, children who received the stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Ruth D, Fay, Michael P, Sagara, Issaka, Dicko, Alassane, Miura, Kazutoyo, Guindo, Merepen A, Guindo, Aldiouma, Sissoko, Mahamadou S, Doumbo, Ogobara K, Diallo, Dapa
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036666/
https://www.ncbi.nlm.nih.gov/pubmed/21247484
http://dx.doi.org/10.1186/1475-2875-10-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036666/
https://www.ncbi.nlm.nih.gov/pubmed/21247484
http://dx.doi.org/10.1186/1475-2875-10-13

Ejemplares similares